(Q33386386)

26 July 2017

title

Prevention and treatment of cardiomyopathy and heart failure in patients receiving cancer chemotherapy (English)

1 reference

26 July 2017

1 reference

1 reference

1 reference

Daniela Cardinale

1

1 reference

26 July 2017

Alessandro Colombo

series ordinal

2

1 reference

26 July 2017

Carlo Maria Cipolla

series ordinal

3

1 reference

26 July 2017

publication date

1 December 2008

1 reference

Current treatment options in cardiovascular medicine

26 July 2017

published in

1 reference

26 July 2017

volume

10

1 reference

26 July 2017

issue

6

1 reference

26 July 2017

page(s)

486-495

1 reference

Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugs

26 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11936-008-0041-X

Doxorubicin Cardiomyopathy: Evaluation by Phonocardiography, Endomyocardial Biopsy, and Cardiac Catheterization

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11936-008-0041-X

Reversibility of severe left ventricular dysfunction due to doxorubicin cardiotoxicity. Report of three cases

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11936-008-0041-X

Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology

21 January 2018

1 reference

12 December 2020

Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition

1 reference

12 December 2020

Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro

1 reference

12 December 2020

Five cases of anthracycline-induced cardiomyopathy effectively treated with carvedilol

1 reference

12 December 2020

Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the Cardiology Committee of the Childrens Cancer Study Group

1 reference

12 December 2020

Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management

1 reference

12 December 2020

Doxorubicin-induced cardiomyopathy treated with carvedilol.

1 reference

12 December 2020

Response of doxorubicin-induced cardiomyopathy to the current management strategy of heart failure

1 reference

12 December 2020

Mechanism of troponin elevations in patients with acute ischemic stroke

1 reference

12 December 2020

Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy

1 reference

12 December 2020

The prevention and management of cardiovascular complications of chemotherapy in patients with cancer

1 reference

12 December 2020

Simultaneous angiotensin converting enzyme inhibition moderates ventricular dysfunction caused by doxorubicin

1 reference

12 December 2020

Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines

1 reference

12 December 2020

Treatment with angiotensin-converting-enzyme inhibitor for epirubicin-induced dilated cardiomyopathy

1 reference

12 December 2020

1 reference

12 December 2020

Epirubicin cardiotoxicity: a study of 135 patients with advanced breast cancer

1 reference

12 December 2020

Relation between gender, etiology and survival in patients with symptomatic heart failure.

1 reference

12 December 2020

Prevention of doxorubicin (adriamycin)-induced cardiomyopathy by simultaneous administration of angiotensin-converting enzyme inhibitor assessed by acoustic densitometry

1 reference

12 December 2020

An angiotensin-converting enzyme inhibitor protects against doxorubicin-induced impairment of calcium handling in neonatal rat cardiac myocytes

1 reference

12 December 2020

ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997

1 reference

12 December 2020

Troponin as a marker of myocardiac damage in drug-induced cardiotoxicity.

1 reference

12 December 2020

Doxorubicin-induced congestive heart failure in adults

1 reference

12 December 2020

Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment

1 reference

12 December 2020

Predicting cancer therapy-induced cardiotoxicity: the role of troponins and other markers

1 reference

12 December 2020

Beta-blockade intolerance in anthracycline-induced cardiomyopathy

1 reference

12 December 2020

Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat.

1 reference

12 December 2020

Beneficial effects of angiotensin-converting enzyme inhibition in adriamycin-induced cardiomyopathy in hamsters

1 reference

12 December 2020

A clinicopathologic analysis of adriamycin cardiotoxicity

1 reference

12 December 2020

Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management

1 reference

12 December 2020

Potential protective role of angiotensin-converting enzyme inhibitors captopril and enalapril against adriamycin-induced acute cardiac and hepatic toxicity in rats

1 reference

12 December 2020

Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention

1 reference

12 December 2020

Cardiac toxicity in breast cancer survivors: review of potential cardiac problems.

1 reference

12 December 2020

Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy

1 reference

12 December 2020

Protective effects of carvedilol against anthracycline-induced cardiomyopathy

1 reference

12 December 2020

Is MUGA scan necessary in patients with low-risk breast cancer before doxorubicin-based adjuvant therapy? Multiple gated acquisition

1 reference

12 December 2020

Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy

1 reference

12 December 2020

Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy

1 reference

12 December 2020

Beta-blockade in adriamycin-induced cardiomyopathy

1 reference

12 December 2020

Reversible doxorubicin-induced congestive heart failure

1 reference

12 December 2020

Role and importance of biochemical markers in clinical cardiology.

1 reference

12 December 2020

Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients

1 reference

12 December 2020

Detection of anthracycline-induced cardiotoxicity.

1 reference

12 December 2020

Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies

1 reference

12 December 2020

10.1007/S11936-008-0041-X

Identifiers

DOI

1 reference

26 July 2017

1 reference